Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study
Authors
Keywords
-
Journal
HEMATOLOGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-09-29
DOI
10.1002/hon.3216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oncologist and Patient Preferences for Novel Agents in First-Line Treatment for Chronic Lymphocytic Leukemia: Commonalities and Disconnects
- (2021) Hannah Le et al. Patient Preference and Adherence
- Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
- (2021) Petra Langerbeins et al. ACTA HAEMATOLOGICA
- Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
- (2021) Francesca Romana Mauro et al. Cancers
- Application of Discrete Choice Experiment in Health Care: A Bibliometric Analysis
- (2021) Yue Wang et al. Frontiers in Public Health
- Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures
- (2021) Michael Hallek et al. AMERICAN JOURNAL OF HEMATOLOGY
- Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience
- (2020) Anthony R. Mato et al. BLOOD
- Health-related quality of life and economic burden of chronic lymphocytic leukemia in the era of novel targeted agents
- (2020) Catherine Waweru et al. CURRENT MEDICAL RESEARCH AND OPINION
- Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2020) B. Eichhorst et al. ANNALS OF ONCOLOGY
- Clinical characteristics of a large multi-center cohort of people with multiple sclerosis over age 60
- (2020) Le H. Hua et al. Multiple Sclerosis and Related Disorders
- Treatment decision-making in chronic lymphocytic leukaemia: Key factors for healthcare professionals. PRELIC study
- (2019) Concepción Boqué et al. Journal of Geriatric Oncology
- Chronic lymphocytic leukemia: 2019 update on diagnosis, risk stratification and treatment
- (2019) Michael Hallek AMERICAN JOURNAL OF HEMATOLOGY
- Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer
- (2019) Eva María Ciruelos et al. EUROPEAN JOURNAL OF CANCER CARE
- Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections
- (2019) Rossana Maffei et al. BLOOD REVIEWS
- Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research
- (2019) Johannes M. Giesinger et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- (2018) Jacqueline C. Barrientos et al. Clinical Lymphoma Myeloma & Leukemia
- A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia
- (2017) Tamar Tadmor et al. Expert Review of Hematology
- Patient, physician, and general population preferences for treatment characteristics in relapsed or refractory chronic lymphocytic leukemia: A conjoint analysis
- (2016) Erik Landfeldt et al. LEUKEMIA RESEARCH
- Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned?
- (2015) Laura Cannella et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
- (2013) F. Reed Johnson et al. VALUE IN HEALTH
- Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia
- (2012) Jane A. Freeman et al. LEUKEMIA & LYMPHOMA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More